Should I Buy IPX? IPX 2026 Analysis

Should You Buy Iperionx Ltd (IPX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

43.100

1 Day change

2.21%

52 Week Range

61.450

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient trader: momentum is still bearish and price is trading below a key support zone.
No Intellectia buy signals (AI Stock Picker / SwingMax) to justify an aggressive pre-market entry.
While the company’s strategic narrative is positive (domestic titanium + capacity expansion), the most recent notable analyst commentary is sharply negative and argues the stock is materially overvalued.
Best stance here is to stay on the sidelines until price reclaims key levels (at least back above ~47.0 and ideally the ~53 pivot) or a proprietary entry signal appears.

Technical Analysis

Price (pre-market 46.3) is below S1 support (47.021) and closer to S2 (43.142), which keeps near-term trend pressure to the downside.
MACD histogram is negative (-1.096) and negatively expanding → bearish momentum is strengthening, not stabilizing yet.
RSI(6) ~30.94 is near oversold; this can support a short-term bounce, but it’s not a confirmed reversal signal by itself.
Moving averages are converging → potential base-building, but current momentum indicators still favor bears.
Key levels: Pivot 53.301 (major recovery trigger), Resistance R1 59.582; Supports 47.021 then 43.142.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

Shareholder letter emphasizes expanding domestic titanium production tied to national security/defense supply chain messaging.
HAMR™ and HSPT™ technologies described as having achieved commercialization (if adoption follows, could be a meaningful catalyst).
Plan to scale Virginia production capacity to ~1,400 tons/year by mid-2027 to serve defense and maritime demand.
Titan Critical Minerals Project fully permitted; Definitive Feasibility Study expected Q2 2026 (potential event-driven milestone).

Neutral/Negative Catalysts

with bearish MACD expansion.
Spruce Point Capital issued a strongly bearish forensic-style critique alleging expectations/valuation are too high and raising concerns around commercial execution and financial reporting accuracy; cites potential downside of 70%–95% in certain scenarios.

Financial Performance

Financial snapshot unavailable due to data error ("list index out of range"), so latest quarter financials and the latest quarter season cannot be assessed from the provided data.
No valuation data provided, limiting the ability to corroborate or refute over/undervaluation claims using fundamentals.
Congress trading: No recent congress trading data available (last 90 days).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Latest provided analyst-related update (2025-11-12): Spruce Point Capital issued a highly bearish note, arguing the stock is significantly overvalued and highlighting execution and reporting concerns; estimates large downside risk (70%–95%) under some scenarios.
Recent trend from the provided dataset: no offsetting upgrades/raised price targets are shown—net tone is negative.
Wall Street pros/cons view (based on provided info):
- Pros: strategic positioning in domestic titanium supply chain; planned capacity expansion; stated commercialization progress.
- Cons: credibility/valuation concerns raised by Spruce Point; commercialization/execution risk; current market price action supports a bearish/defensive stance.

Analyst Rating

Wall Street analysts forecast IPX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IPX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 42.170

Low

Averages

High

Current: 42.170

Low

Averages

High

Spruce Point Capital

downgrade

AI Analysis

2025-11-12

Reason

Spruce Point Capital

Price Target

AI Analysis

2025-11-12

downgrade

Reason

Spruce Point Capital, in a research note, said that after conducting a forensic review of IperionX and its ambitions of becoming a vertically integrated producer of titanium powders and products, the firm believes that investor expectations are too high, and it faces significant challenges in commercial efforts that may not be fully reflected in its valuation. Spruce Point also expressed concerns with the accuracy of its financial reporting and says it does not believe the end markets to be attractive or that its highly promoted HAMR process is likely to "revolutionize" the industry. Based on the firm's analysis, Spruce Point advises investors to exercise caution because the shares may be significantly overvalued, with potential downside risk of 70% - 95% under certain scenarios. Reference Link

Roth Capital

Buy

maintain

$64 -> $74

2025-10-01

Reason

Roth Capital

Price Target

$64 -> $74

2025-10-01

maintain

Buy

Reason

Roth Capital raised the firm's price target on IperionX to $74 from $64 and keeps a Buy rating on the shares. The firm cites the company's FY25 results and the receipt of additional government funding as part of its existing $47.1M award, the analyst tells investors in a research note. Roth adds that its higher price target reflects lower future dilution assumptions and a higher multiple on 2029 EBITDA.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for IPX

Unlock Now

IPX Should I Buy

IPX Should I Buy

Should You Buy Iperionx Ltd (IPX) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch